Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug
- Products
-
- Rifampin Capsules USP
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 26,352 bottles
- About this recall
- Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06